Published Erratum

. 2018 Aug;24(8):1290-1291.

doi: 10.1038/s41591-018-0097-4.

Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

Bjoern Chapuy^{1

2}, Chip Stewart³, Andrew J Dunford³, Jaegil Kim³, Atanas Kamburov³, Robert A Redd⁴, Mike S Lawrence^{2

3

5}, Margaretha G M Roemer¹, Amy J Li⁶, Marita Ziepert⁷, Annette M Staiger^{8

9}, Jeremiah A Wala³, Matthew D Ducar¹⁰, Ignaty Leshchiner³, Ester Rheinbay³, Amaro Taylor-Weiner³, Caroline A Coughlin¹, Julian M Hess³, Chandra S Pedamallu³, Dimitri Livitz³, Daniel Rosebrock³, Mara Rosenberg³, Adam A Tracy³, Heike Horn⁸, Paul van Hummelen¹⁰, Andrew L Feldman¹¹, Brian K Link¹², Anne J Novak¹¹, James R Cerhan¹¹, Thomas M Habermann¹¹, Reiner Siebert¹³, Andreas Rosenwald¹⁴, Aaron R Thorner¹⁰, Matthew L Meyerson^{2

3}, Todd R Golub^{2

3}, Rameen Beroukhim^{2

3}, Gerald G Wulf¹⁵, German Ott⁹, Scott J Rodig^{2

16}, Stefano Monti⁶, Donna S Neuberg^{2

4}, Markus Loeffler⁷, Michael Pfreundschuh¹⁷, Lorenz Trümper¹⁵, Gad Getz^{18

19

20}, Margaret A Shipp^{21

22}

Affiliations

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
² Harvard Medical School, Boston, MA, USA.
³ Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
⁴ Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
⁵ Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
⁶ Boston University School of Medicine, Section of Computational Biomedicine, Boston, MA, USA.
⁷ Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, Leipzig, Germany.
⁸ Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, and University of Tuebingen, Tuebingen, Germany.
⁹ Department of Clinical Pathology, Robert-Bosch Krankenhaus, Stuttgart, Germany.
¹⁰ Dana-Farber Cancer Institute, Center for Cancer Genome Discovery, Boston, MA, USA.
¹¹ Mayo Clinic, Rochester, MN, USA.
¹² University of Iowa, Iowa City, IA, USA.
¹³ Department for Human Genetics, University Ulm, Ulm, Germany.
¹⁴ Department of Pathology, University of Würzburg, Würzburg, Germany.
¹⁵ Department of Hematology and Oncology, Georg-August University Göttingen, Göttingen, Germany.
¹⁶ Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
¹⁷ Department of Medicine I, Saarland University, Homburg, Germany.
¹⁸ Harvard Medical School, Boston, MA, USA. gadgetz@broadinstitute.org.
¹⁹ Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA. gadgetz@broadinstitute.org.
²⁰ Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. gadgetz@broadinstitute.org.
²¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. margaret_shipp@dfci.harvard.edu.
²² Harvard Medical School, Boston, MA, USA. margaret_shipp@dfci.harvard.edu.

PMID: 29955182
DOI: 10.1038/s41591-018-0097-4

Published Erratum

Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

Bjoern Chapuy et al. Nat Med. 2018 Aug.

. 2018 Aug;24(8):1290-1291.

doi: 10.1038/s41591-018-0097-4.

Authors

Affiliations

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
² Harvard Medical School, Boston, MA, USA.
³ Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
⁴ Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
⁵ Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
⁶ Boston University School of Medicine, Section of Computational Biomedicine, Boston, MA, USA.
⁷ Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, Leipzig, Germany.
⁸ Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, and University of Tuebingen, Tuebingen, Germany.
⁹ Department of Clinical Pathology, Robert-Bosch Krankenhaus, Stuttgart, Germany.
¹⁰ Dana-Farber Cancer Institute, Center for Cancer Genome Discovery, Boston, MA, USA.
¹¹ Mayo Clinic, Rochester, MN, USA.
¹² University of Iowa, Iowa City, IA, USA.
¹³ Department for Human Genetics, University Ulm, Ulm, Germany.
¹⁴ Department of Pathology, University of Würzburg, Würzburg, Germany.
¹⁵ Department of Hematology and Oncology, Georg-August University Göttingen, Göttingen, Germany.
¹⁶ Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
¹⁷ Department of Medicine I, Saarland University, Homburg, Germany.
¹⁸ Harvard Medical School, Boston, MA, USA. gadgetz@broadinstitute.org.
¹⁹ Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA. gadgetz@broadinstitute.org.
²⁰ Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. gadgetz@broadinstitute.org.
²¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. margaret_shipp@dfci.harvard.edu.
²² Harvard Medical School, Boston, MA, USA. margaret_shipp@dfci.harvard.edu.

PMID: 29955182
DOI: 10.1038/s41591-018-0097-4

Abstract

In the version of this article originally published, an asterisk was omitted from Fig. 1a. The asterisk has been added to the figure. Additionally, a "NOTCH2" label was erroneously included in Fig. 4a. The label has been removed. The errors have been corrected in the PDF and HTML versions of this article.

PubMed Disclaimer

Erratum for

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, Lawrence MS, Roemer MGM, Li AJ, Ziepert M, Staiger AM, Wala JA, Ducar MD, Leshchiner I, Rheinbay E, Taylor-Weiner A, Coughlin CA, Hess JM, Pedamallu CS, Livitz D, Rosebrock D, Rosenberg M, Tracy AA, Horn H, van Hummelen P, Feldman AL, Link BK, Novak AJ, Cerhan JR, Habermann TM, Siebert R, Rosenwald A, Thorner AR, Meyerson ML, Golub TR, Beroukhim R, Wulf GG, Ott G, Rodig SJ, Monti S, Neuberg DS, Loeffler M, Pfreundschuh M, Trümper L, Getz G, Shipp MA. Chapuy B, et al. Nat Med. 2018 May;24(5):679-690. doi: 10.1038/s41591-018-0016-8. Epub 2018 Apr 30. Nat Med. 2018. PMID: 29713087 Free PMC article.

Cited by

Characterizing the Cell-Free Transcriptome in a Humanized Diffuse Large B-Cell Lymphoma Patient-Derived Tumor Xenograft Model for RNA-Based Liquid Biopsy in a Preclinical Setting.
Decruyenaere P, Daneels W, Morlion A, Verniers K, Anckaert J, Tavernier J, Offner F, Vandesompele J. Decruyenaere P, et al. Int J Mol Sci. 2024 Sep 16;25(18):9982. doi: 10.3390/ijms25189982. Int J Mol Sci. 2024. PMID: 39337470 Free PMC article.
Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center-derived B-cell lymphomas.
Tanaka Y, Momose S, Tabayashi T, Sawada K, Yamashita T, Higashi M, Sagawa M, Tokuhira M, Rosenwald A, Kizaki M, Tamaru JI. Tanaka Y, et al. Cancer Sci. 2020 Feb;111(2):749-759. doi: 10.1111/cas.14286. Epub 2020 Jan 13. Cancer Sci. 2020. PMID: 31849147 Free PMC article.
Development and validation of novel models based on clonality immunoglobulin gene rearrangement for evaluation of bone marrow involvement and prognostic prediction in patients with diffuse large B-cell Lymphoma: a multicenter retrospective study.
Liu Z, Li Q, Liu R, Ding Y, Liao Y, Hu L, Pu L, Zhu C, Zhang S, Xiong S. Liu Z, et al. Front Immunol. 2025 Apr 14;16:1547056. doi: 10.3389/fimmu.2025.1547056. eCollection 2025. Front Immunol. 2025. PMID: 40297584 Free PMC article.
Comprehensive Genetic Analysis of Central Nervous System Involvement in Mycosis Fungoides: A Case Report.
Nakata Y, Ouchi F, Yoshifuji K, Sadato D, Yamamoto K, Kawase Y, Mori T. Nakata Y, et al. EJHaem. 2025 Aug 1;6(4):e70118. doi: 10.1002/jha2.70118. eCollection 2025 Aug. EJHaem. 2025. PMID: 40757161 Free PMC article.
Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL.
Hartert KT, Wenzl K, Krull JE, Manske M, Sarangi V, Asmann Y, Larson MC, Maurer MJ, Slager S, Macon WR, King RL, Feldman AL, Gandhi AK, Link BK, Habermann TM, Yang ZZ, Ansell SM, Cerhan JR, Witzig TE, Nowakowski GS, Novak AJ. Hartert KT, et al. Leukemia. 2021 Feb;35(2):522-533. doi: 10.1038/s41375-020-0766-4. Epub 2020 Mar 5. Leukemia. 2021. PMID: 32139889 Free PMC article. Clinical Trial.

See all "Cited by" articles

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

Affiliations

Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

Authors

Affiliations

Abstract

Erratum for

Similar articles

Cited by

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous

Abstract

Erratum for

Similar articles

Cited by

Publication types

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous